About Saleem

Saleem Kamili, PhD, is Chief of the Laboratory Branch, Division of Viral Hepatitis at the US Centers for Disease Control and Prevention (CDC). He has been working for 20 years at CDC on various aspects of hepatitis viruses including pathogenesis, vaccine design and delivery and diagnostics. Dr. Kamili received the Young Scientist Award and Himalayan Gold Medal during his graduate studies and was recently awarded the MS Balayan Medal for his contributions to the study of hepatitis E. He co-authored CDC’s updated guidelines on testing for hepatitis C virus infection. He serves as Associate Editor of the Journal of Medical Virology and Journal of Clinical Virology. His laboratory is actively involved in improving viral hepatitis diagnostics globally and is partnering with various international institutions in achieving this goal.

This speaker will be presenting at the following session(s)

  • Testing interventions

    Ballroom 1

    Day: 2 November

    Time: 14:00

    Chairs: Dr. Maria Cassia Mendes-Correa, Sao Paulo University, Brazil and Dr. Francesco Negro Geneva University Hospital, Switzerland

    Presentations:

    • Introduction including a brief overview of WHO testing guidelines and implementation.
    • Prof. Philippa Easterbrook, World Health Organization
    • Diagnostics: present and future innovations.
    • Dr. Saleem Kamili, US Centers for Disease Control and Prevention
    • Are HBV community-based screening campaigns feasible and acceptable: the PROLIFICA experience.
    • Dr. Maud Lemoine, Imperial College London, UK
    • Scaling-up a national screening programme for hepatitis C.
    • Dr. Radi Hammad, Ministry of Health, Egypt
    • Q & A session.

    Session objectives:

    • Review the scientific, logistical, ethical and political process leading to the implementation of state-of-the-art testing for viral hepatitis.
    • Discuss the feasibility and validity of diagnostic algorithm simplifications.
    • Define what testing strategies should be applied in different settings.
    • Discuss the preliminary results of testing strategies in selected areas.